Quantum Biopharma (QNTM) Cash & Equivalents Growth (3y) (2021 - 2026)
Quantum Biopharma (QNTM) Cash & Equivalents Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 24.73% |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -40.88% |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -28.55% |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 21.66% |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -16.07% |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.59 Bn | 54.83 Bn | 3.31 Bn | -8.88% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.88% |
| Dec 31, 2025 | -51.77% |
| Sep 30, 2025 | -44.60% |
| Jun 30, 2025 | -42.55% |
| Mar 31, 2025 | -44.60% |
| Dec 31, 2024 | -44.60% |
| Sep 30, 2024 | -46.02% |
| Jun 30, 2024 | -42.64% |
| Mar 31, 2024 | -61.90% |
| Sep 30, 2023 | 41.82% |
| Jun 30, 2023 | -0.29% |
| Mar 31, 2023 | 15.95% |
| Dec 31, 2022 | 41.38% |
| Mar 31, 2022 | 30.43% |
| Dec 31, 2021 | 30.10% |